Supplier of Oral Solid Dosage Forms (Tablets/Capsules)

The contract is for the supply of FDA-approved oral solid dosage forms, including tablets and capsules, in various strengths and package sizes, specifically for research use by the Center for Drug Evaluation and Research. The solicitation, posted on May 4, 2026, requires responses by 6:00 PM on May 15, 2026, and is classified as a subcontract under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The contracting authority is the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, and the place of performance and detailed office address are unspecified. The medications must comply with all applicable FDA regulations and standards for quality, safety, and efficacy, and are intended solely for internal research purposes, not for clinical use or distribution. The contract does not specify a set-aside category, and interested parties must access the full solicitation via the provided SAM.gov link.